This is a new finding as SGLT2I by virtue of their afferent arteriolar vasoconstriction should actually increase in the initial stage followed by maintenance of the previous level of EPO but we found a decreasing trend, the reason of which needs to be further clarified in large scale trials.
← all excerpts
Administration of Once-daily Canagliflozin to a Non-diabetic Patient in Addition to Standard Aerobic Exercise: A Case Report.
1
—
—